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Abstract
Introduction: Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes
mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome. Waist-to-height-ratio has
been proposed as a useful tool for assessing abdominal obesity, correcting other measurements for the height of the
individual. We compared the ability of several anthropometric measurements to predict the presence of type-2 diabetes,
hyperglycemia, hypertension, atherogenic dyslipidemia or metabolic syndrome.
Materials and Methods: In our cross-sectional analyses we included 7447 Spanish individuals at high cardiovascular risk,
men aged 55–80 years and women aged 60–80 years, from the PREDIMED study. Logistic regression models were fitted to
evaluate the odds ratio of presenting each cardiovascular risk factor according to various anthropometric measures. The
areas under the receiver-operating characteristic curve (AUC) were used to compare the predictive ability of these
measurements.
Results: In this relatively homogeneous cohort with 48.6% of type-2 diabetic individuals, the great majority of the studied
anthropometric parameters were significantly and positively associated with the cardiovascular risk factors. No association
was found between BMI and body weight and diabetes mellitus. The AUCs for the waist-to-height ratio and waist
circumference were significantly higher than the AUCs for BMI or weight for type-2 diabetes, hyperglycemia, atherogenic
dyslipidemia and metabolic syndrome. Conversely, BMI was the strongest predictor of hypertension.
Conclusions: We concluded that measures of abdominal obesity showed higher discriminative ability for diabetes mellitus,
high fasting plasma glucose, atherogenic dyslipidemia and metabolic syndrome than BMI or weight in a large cohort of
elderly Mediterranean individuals at high cardiovascular risk. No significant differences were found between the predictive
abilities of waist-to-height ratio and waist circumference on the metabolic disease.
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Introduction
Overweight and obesity are major risk factors for type-2
diabetes mellitus, cardiovascular morbidity and mortality, cancer
and other chronic health diseases and conditions [1,2,3]. To
understand these associations, not only the total amount of body
fat is important, but also the distribution of fat. Evidence suggests
that central fat or ‘‘android distribution’’ is more strongly related
to cardiovascular risk than peripheral fat or ‘‘gynoid distribution’’
[4]. This may be because abdominal obesity is associated with
increased secretion of fatty acids, adipocytokines, hyperinsulin-
emia, insulin resistance, hypertension and atherogenic dyslipide-
mia, and leads to greater cardiovascular risk [5].
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Several easily obtained anthropometric measurements, can
predict diabetes and other risk conditions, such as hypertension or
metabolic syndrome (MetS). Cross-sectional and prospective
studies have shown that the waist-to-height-ratio (WHtR), waist
circumference (WC), and body mass index (BMI) are able to
predict diabetes and other cardiovascular conditions; however,
WHtR and WC appeared to be better predictors than BMI,
because of the relation between waist circumference and central
obesity [6,7,8].
Although BMI is widely used to assess overweight and obesity, it
does not distinguish fat from muscle or different fat distributions
[9]. Other anthropometric measurements which have been
proposed as useful tools for detecting obesity are the waist
circumference or the waist-to-hip ratio. The main limitation of the
waist-to-hip ratio is that both waist and hip can decrease with
weight reduction and as a consequence changes in the ratio are
frequently small. Waist circumference is also strongly associated
with central obesity. Nevertheless, it may over- or under-evaluate
risk for tall and short individuals with similar waist circumference
[10].
In several studies conducted on Asian and Caucasian popula-
tions, WHtR outperformed BMI in the detection of impaired
fasting plasma glucose (FPG), type-2 diabetes mellitus, hyperten-
sion, MetS and atherogenic dyslipidemia [8,10]. However, with
the exception of an Italian study in relatively few individuals [11];
and two studies in which they had included young and healthy
adults from Crete [12] or Spain [13], this association has not been
evaluated in Mediterranean populations. As far as we know, the
predictive power of anthropometric measurements has not been
assessed in elderly Mediterranean individuals at high cardiovas-
cular risk, for whom the early detection of cardiovascular risk
factors is essential if cardiovascular disease is to be prevented. The
aim of the present study was to compare the predictive value of
several anthropometric measurements on the presence of type-2
diabetes mellitus, hyperglycemia, hypertension, atherogenic dysli-
pidemia and metabolic syndrome in a large cohort of elderly
Mediterranean individuals at high cardiovascular risk from the
PREDIMED study.
Materials and Methods
For PREDIMED Study the respective local institutional review
boards approved the study protocol and all participants provided
written informed consent.
The PREDIMED study (PREvencio´n con DIeta MEDiterra´-
nea) is a large, parallel-group, multicenter, randomized, controlled
clinical trial which aims to assess the effects of the Mediterranean
diet on the primary prevention of cardiovascular disease (CVD)
(www.predimed.org and www.predimed.es) (http://www.
controlled-trials.com/ISRCTN35739639). The PREDIMED
study was conducted in Spain. Recruitment took place between
October 2003 and January 2009, and the 7447 participants were
randomly assigned to one of three interventions (two Mediterra-
nean diets enriched with extra virgin olive oil or mixed nuts, and a
control low-fat diet). The design and methods used in the
PREDIMED study have been described elsewhere [14].
Participants were men aged 55–80 years and women aged 60–
80 years, who were free of CVD at baseline but who had either
type-2 diabetes mellitus or fulfilled at least three or more coronary
heart disease risk factors: current smoking, hypertension (blood
pressure $140/90 mmHg or treatment with antihypertensive
medication), high plasma LDL-cholesterol ($160 mg/dL or lipid-
lowering therapy), low plasma HDL-cholesterol (#40 mg/dL in
men and #50 mg/dL in women), overweight or obesity (BMI
$25 kg/m2), and family history of premature CVD (#55 years in
men and #60 years in women). The exclusion criteria for the
PREDIMED study were the presence of any severe chronic illness,
previous history of CVD, alcohol or drug abuse, BMI $40 kg/m2
and history of allergy or intolerance to olive oil or nuts.
At baseline examination and yearly in follow-up visits, trained
personnel performed anthropometric and blood pressure mea-
surements and obtained samples of fasting blood. Weight and
height were measured with light clothing and no shoes with
calibrated scales and a wall-mounted stadiometer, respectively;
waist circumference was measured midway between the lowest rib
and the iliac crest using an anthropometric tape; blood pressure
was measured using a validated oscillometer [Omron
HEM705CP, Hoofddorp, Netherlands]. in triplicate with a 5-
min interval between each measurement, and the mean of these
values was recorded. We also administered a 137-item validated
food frequency questionnaire [15]; the validated Spanish version
of the Minnesota Leisure Time Physical Activity Questionnaire
[16]; and a 47-item questionnaire about education, lifestyle,
history of illnesses and medication use. Samples of serum, EDTA
plasma, and urine were coded, shipped to central laboratories, and
stored at 280uC until analysis. Laboratory analyses were
performed on frozen serum samples. Serum glucose, cholesterol,
and triglyceride concentrations were measured using standard
enzymatic automated methods. HDL-cholesterol was measured by
enzymatic procedure after precipitation.
For the present study, 7447 individuals were included in the
statistical analysis to assess the association between anthropometric
measurements and diabetes. For the other outcomes (hyperten-
sion, atherogenic dyslipidemia, metabolic syndrome or impaired
fasting plasma glucose) fewer number of individuals (ranging
between 3335 and 7447) were included in the analyses because the
biochemical parameters from all participants were not available.
The criteria for cardiovascular risk factors analysed were the
following: Type-2 diabetes mellitus was defined as previous
diagnosis done by a physician using the WHO criteria [17];
hyperglycemia (defined as having FPG $110 mg/dL ) only non
diabetic individuals at baseline were included [18]; hypertension
(defined as systolic blood pressure (SBP) $130 mmHg, diastolic
blood pressure (DBP) $85 mmHg or if subjects were receiving
antihypertensive treatment); atherogenic dyslipidemia, which was
defined as HDL-cholesterol ,40 mg/dL (,0.9 mmol/L) in men
or ,50 mg/dL (,1.2 mmol/L) in women and TG was
$150 mg/dL ($1.7 mmol/L). Metabolic syndrome and its
components were defined by the updated harmonized Interna-
tional Diabetes Federation (IDF) and the American Heart, Lung,
and Blood Institute (AHA/NHLBI) criteria [19]. MetS was
considered to be present when subjects fulfilled three or more of
the following criteria: a) abdominal obesity (defined as waist
circumference $102 cm in men or $88 cm in women), b) low
HDL cholesterol (defined as ,40 mg/dL in men or ,50 mg/dL
in women or if subjects were receiving fibrate treatment), c)
hypertriglyceridemia (defined as triglyceride concentrations
$150 mg/dL or fibrate treatment), d) hypertension (defined as a
blood pressure level of $130/85 mmHg or if subjects were
receiving antihypertensive medication), and e) hyperglycemia
(defined as FPG concentration $100 mg/dL ($5.6 mmol/L) or
drug treatment for elevated glucose).
Because no interactions were observed between sex and the
main outcomes, analyses were conducted for men and women
together. To determine which anthropometric index was the best
predictor of the metabolic risk factors, two statistical methods
were used. First, multivariable logistic regression analysis was
used to evaluate the association between baseline anthropometric
Waist-to-Height Ratio and Cardiovascular Risk
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measurements (WHtR, calculated as waist in cm divided by
height in cm; waist circumference; BMI, calculated as weight in
kg divided by height in m2; and body weight) and cardiovascular
risk conditions. The adjusted odds ratios (ORs) and 95%
confidence intervals (95%CI) were presented per one standard
deviation change in the respective anthropometric parameter.
Four models were fitted for each measurement: the unadjusted
model; model 1, adjusted for sex, age (continuous) and region;
model 2, adjusted for sex, age, region, current smoking (yes or
no), education (illiterate, elementary education, secondary edu-
cation, university degree) and marital status (single, widow,
separated, religious, married); model 3 or fully-adjusted model,
adjusted for sex, age, region, current smoking (yes or no),
education (illiterate, elementary education, secondary education,
university degree) and marital status (single, widow, separated,
religious, married), total energy intake (continuous variable) and
physical activity (continuous). Secondly, we calculated the areas
under the receiver-operating characteristic (ROC) curves (AUC)
for each model.
The level of significance for all statistical tests was set at P,0.05
for bilateral contrasts. Data were analyzed using the SPSS
statistical package version 19.0. We used Epidat 3.1 software to
estimate the statistical significance of the differences between the
ROC curves areas of all the models according to each
cardiovascular risk factor and according to the algorithm
developed by DeLong and colleagues [20].
Results
The baseline characteristics of anthropometric measurements
and biochemical parameters are presented in Table 1. The mean
age of the population was 67 (standard deviation 66 years). Of all
the subjects analyzed, 82.7% had hypertension, 48.6% were
diabetic, 13.2% had atherogenic dyslipidemia, and 63.7%
metabolic syndrome.
Table 2 summarizes the odds ratios (ORs) and the AUCs for the
associations between baseline anthropometric measurements and
the prevalence of hyperglycemia and diabetes. When we analyzed
the prevalence of hyperglycemia in non diabetic individuals,
including 3335 individuals in the analysis, the ORs for each
additional standard deviation increase were higher for WHtR
(OR: 1.42; 1.29–1.56) and WC (OR: 1.43; 1.29–1.58) followed by
BMI (OR: 1.39; 1.26–1.53) and body weight (OR: 1.37; 1.23–
1.52) in the fully-adjusted model. In all models, the inclusion of
waist circumference was associated with a larger AUC than the
inclusion of weight (P,0.05); The AUC was also larger for models
containing WHtR than those containing weight in models 1, 2 and
in the fully-adjusted model (P,0.05). These results were similar
when we included in the analysis both diabetic and non-diabetic
individuals, or when the cut-off point for FPG was set at
$100 mg/dL (data not shown). In the models evaluating the
presence of diabetes, 7447 individuals were included; we observed
that WHtR and waist circumference were positively associated
with the prevalence of diabetes, whereas these associations were
not apparent for BMI or for body weight. In the unadjusted
models the AUCs when using WHtR and WC as measurements of
adiposity were significantly greater than the AUC when weight
was used instead. In the model 1 and 2, the AUCs of models
including WHtR and WC outperformed those including BMI
(P,0.05). In the fully-adjusted model the AUC of model including
WHtR also outperformed those including BMI (P,0.05).
Table 3 shows the ORs and the AUCs for the associations
between anthropometric measurements and the prevalence of
various cardiovascular risk factors. All the anthropometric
parameters were positively associated with these cardiovascular
risk factors. We included 7414 individuals in the models
evaluating hypertension. BMI appeared to be the best predictor
of hypertension. In the first model, the AUC for BMI was
significantly greater than the AUC for WHtR or waist
circumference but the magnitude of the difference was tiny
(AUCs: 0.67; 0.66; 0.66, respectively); also in the fully-adjusted
model the AUC for the prediction using BMI (AUC: 0.68) was
significantly better than that using WHtR or waist circumfer-
ence (AUCs: 0.67; P,0.05 for the comparison between both
areas). A total of 6786 individuals were included in the
evaluation of atherogenic dyslipidemia. WHtR and WC had
higher ORs than BMI or body weight. These measurements
showed a reasonably good predictive value; in the fully-adjusted
model, the AUCs for models including WHtR or WC (AUC:
0.62 for both) were significantly greater than for those including
weight (AUC: 0.60; P,0.05).
The strongest associations were observed for metabolic
syndrome, which was evaluated in 6906 individuals (Table 3).
For one SD increase in WHtR the odds of having MetS was 2.70
(95% CI: 2.52–2.89) and the OR of WC was 2.95 (2.75–3.17) in





Body mass index, kg/m2 29.9663.85
Waist circumference, cm 100.45610.34
Current smoker, n (%) 1047 (14.1)
Physical activity (METS-h/d) 3.8463.98
Systolic blood pressure, mmHg 148.61620.07
Diastolic blood pressure, mmHg 82.84610.58
Hypertension, n (%) 6162 (82.7)
Diabetes, n (%) 3616 (48.6)
Atherogenic dyslipidemia, n (%) 898 (13.2)
Metabolic syndrome, n (%) 4399 (63.7)
Hypercholesterolemia, n (%) 5383 (72.3)
Total cholesterol, mg/dL 206.76638.11
HDL cholesterol, mg/dL 52.77613.16
LDL cholesterol, mg/dL 130.31633.98
Triglycerides, mg/dL 133.54674.85
Fasting plasma glucose, mg/dL 120.56641.11
Marital status Single, n (%) 302 (4.1)
Married, n (%) 5673 (76.3)
Widowed, n (%) 1219 (16.4)
Divorced, n (%) 221 (3.0)
Educational level Primary education or
less, n (%)
5792 (77.8)
Secondary education, n (%) 1121 (15.1)
Higher education, n (%) 534 (7.2)
Use of antihypertensive agents, % (n) 5416 (72.7)
Use of oral hypoglycaemic agents, % (n) 2386 (32.0)
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein. Data
are expressed as mean 6 SD or number (percent).
doi:10.1371/journal.pone.0043275.t001
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the fully-adjusted model. These measures also had a good
predictive ability; their inclusion in the fully-adjusted models
(model 3) showed AUCs of 0.74 for WHtR and 0.76 for WC.
Moreover, in all models the AUCs after inclusion of either WHtR
or WC significantly outperformed the areas under the curve when
BMI or body weight were used instead (P,0.05).
Table 2. Association between baseline anthropometric measurements (OR per one additional standard deviation) and the
prevalence of high FPG of non diabetic individuals at baseline or T2DM. ROC analysis with Areas Under the Curve (AUC).
WHtR Waist Circumference BMI Weight
OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI)
FPG $110 mg/dL (n = 3335)
Unadjusted 1.37 (1.25–1.51) 0.59b (0.57–0.62) 1.47 (1.34–1.62) 0.61 (0.58–0.63) 1.33 (1.22–1.46) 0.59b(0.56–0.61) 1.39 (1.27–1.52) 0.59b(0.56–0.62)
Model 1 1.42 (1.30–1.57) 0.61 (0.59–0.64) 1.43 (1.29–1.58) 0.61 (0.59–0.64) 1.39 (1.26–1.52) 0.61 (0.58–0.63) 1.36 (1.23–1.51) 0.59a,b(0.57–0.62)
Model 2 1.42 (1.29–1.56) 0.62 (0.59–0.64) 1.42 (1.29–1.57) 0.62 (0.59–0.64) 1.38 (1.26–1.52) 0.61 (0.58–0.64) 1.36 (1.23–1.51) 0.60a,b(0.57–0.63)
Model 3 1.42 (1.29–1.56) 0.62 (0.60–0.65) 1.43 (1.29–1.58) 0.62 (0.59–0.65) 1.39 (1.26–1.53) 0.61 (0.59–0.64) 1.37 (1.23–1.52) 0.60a,b(0.67–0.63)
DIABETES MELLITUS (n = 7447)
Unadjusted 1.12 (1.07–1.17) 0.53b (0.52–0.54) 1.16 (1.11–1.21) 0.54 (0.52–0.55) 0.96 (0.92–1.01) 0.51b (0.49–0.52) 1.01 (0.97–1.06) 0.50a,b(0.49–0.52)
Model 1 1.10 (1.05–1.15) 0.58 (0.56–0.59) 1.12 (1.06–1.17) 0.57a (0.56–0.59)0.99 (0.94–1.04) 0.57a,b(0.55–0.58) 0.95 (0.91–1.01) 0.57a(0.56–0.58)
Model 2 1.09 (1.04–1.14) 0.59 (0.58–0.61) 1.11 (1.05–1.16) 0.59 (0.58–0.60) 0.97 (0.93–1.02) 0.58a,b(0.57–0.60) 0.95 (0.90–1.01) 0.59 (0.57–0.60)
Model 3 1.12 (1.07–1.18) 0.61 (0.60–0.63) 1.11 (1.06–1.17) 0.61 (0.60–0.62) 0.98 (0.93–1.02) 0.61a (0.59–0.62) 0.96 (0.91–1.01) 0.61 (0.60–0.62)
Regression logistic models: Odds Ratio for one SD increase in anthropometric measurements. Model 1, adjusted for sex, age (continuous) and region; Model 2, adjusted
for sex, age, region, current smoking (yes or no), education (illiterate, elementary education, secondary education, university degree) and marital status (single, widow,
separated, religious, married); Model 3, adjusted for sex, age, region, current smoking (yes or no), education (illiterate, elementary education, secondary education,
university degree), marital status (single, widow, separated, religious, married), total energy intake (continuous), physical activity (continuous). Abbreviations: FPG,
fasting plasma glucose; T2DM, type-2 diabetes mellitus; WHtR, waist-to-height ratio; BMI, body mass index.
aP value ,0.05 compared to WHtR.
bP value ,0.05 compared to waist circumference.
doi:10.1371/journal.pone.0043275.t002
Table 3. Association between baseline anthropometric measurements (OR per one additional standard deviation) and the
prevalence of cardiovascular risk factors. ROC analysis with Areas Under the Curve (AUC).
WHtR Waist Circumference BMI Weight
OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI) OR (95% CI) AUC (95% CI)
HYPERTENSION (n = 7414)
Unadjusted 1.64 (1.48–1.82) 0.63 (0.60–0.66) 1.53 (1.39–1.69) 0.61 (0.59–0.64) 1.69 (1.52–1.89) 0.63 (0.61–0.66) 1.42 (1.28–1.58) 0.59a(0.57–0.62)
Model 1 1.57 (1.42–1.75) 0.66 (0.63–0.69) 1.59 (1.43–1.77) 0.66 (0.63–0.69) 1.73 (1.55–1.93) 0.67a,b(0.65–0.70) 1.72 (1.53–1.94) 0.67 (0.64–0.69)
Model 2 1.57 (1.41–1.74) 0.66 (0.64–0.69) 1.59 (1.43–1.77) 0.67 (0.64–0.69) 1.71 (1.53–1.91) 0.68a,b (0.65–0.71) 1.71 (1.52–1.93) 0.67 (0.65–0.70)
Model 3 1.58 (1.43–1.76) 0.67 (0.64–0.70) 1.60 (1.44–1.78) 0.67 (0.64–0.70) 1.73 (1.55–1.94) 0.68a,b(0.66–0.71) 1.73 (1.53–1.95) 0.68 (0.66–0.71)
ATHEROGENIC DYSLIPIDEMIA (n = 6786)
Unadjusted 1.39 (1.29–1.49) 0.60 (0.58–0.62) 1.29 (1.20–1.38) 0.57a(0.55–0.59) 1.36 (1.27–1.46) 0.59b(0.57–0.61) 1.16 (1.09–1.25) 0.54a,b(0.52–0.56)
Model 1 1.36 (1.27–1.46) 0.61 (0.59–0.63) 1.36 (1.27–1.46) 0.61 (0.59–0.63) 1.32 (1.24–1.42) 0.60 (0.59–0.62) 1.32 (1.22–1.42) 0.59a,b(0.58–0.62)
Model 2 1.37 (1.28–1.47) 0.62 (0.60–0.64) 1.37 (1.28–1.47) 0.62 (0.60–0.64) 1.34 (1.25–1.43) 0.61 (0.59–0.63) 1.31 (1.22–1.43) 0.60a,b(0.58–0.62)
Model 3 1.36 (1.27–1.46) 0.62 (0.60–0.64) 1.36 (1.27–1.46) 0.62 (0.60–0.64) 1.32 (1.23–1.42) 0.61 (0.60–0.63) 1.31 (1.21–1.41) 0.60a,b(0.59–0.62)
METABOLIC SYNDROME (n = 6906)
Unadjusted 2.74 (2.51–2.93) 0.74 (0.72–0.75) 2.47 (2.32–2.63) 0.72a(0.71–0.73) 2.14 (2.01–2.27) 0.69a,b(0.68–0.70) 1.67 (1.58–1.76) 0.63a,b(0.62–0.65)
Model 1 2.73 (2.55–2.92) 0.74b(0.73–0.75) 2.98 (2.78–3.19) 0.76 (0.74–0.77) 2.12 (1.99–2.25) 0.70a,b(0.68–0.71) 2.20 (2.06–2.35) 0.69a,b(0.68–0.70)
Model 2 2.73 (2.55–2.92) 0.74b(0.73–0.75) 2.97 (2.77–3.19) 0.76 (0.74–0.77) 2.11 (1.98–2.24) 0.70a,b(0.68–0.71) 2.21 (2.07–2.36) 0.69a,b(0.68–0.71)
Model 3 2.70 (2.52–2.89) 0.74b (0.73–0.76) 2.95 (2.75–3.17) 0.76 (0.75–0.77) 2.09 (1.97–2.23) 0.70a,b(0.69–0.72) 2.20 (2.06–2.35) 0.70a,b(0.69–0.72)
Regression logistic models: Odds Ratio for one SD increase in anthropometric measurements. Model 1, adjusted by sex, age (continuous) and region; Model 2, adjusted
by sex, age, region, current smoking (yes or no), education (illiterate, elementary education, secondary education, university degree) and marital status (single, widow,
separated, religious, married); Model 3, adjusted for sex, age, region, current smoking (yes or no), education (illiterate, elementary education, secondary education,
university degree), marital status (single, widow, separated, religious, married), total energy intake (continuous), physical activity (continuous). Abbreviations: WHtR,
waist-to-height ratio; BMI, body mass index.
aP value ,0.05 compared to WHtR.
bP value ,0.05 compared to waist circumference.
doi:10.1371/journal.pone.0043275.t003
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Discussion
In the present study conducted in a large Mediterranean cohort
at high risk of CVD, our main finding was that measures of overall
and central obesity were strongly associated not only with the
prevalence of hyperglycemia and diabetes, but also with other
cardiovascular risk factors, such as hypertension, atherogenic
dyslipidemia and metabolic syndrome. These risk factors were
used in our analysis because they have been associated with obesity
and are independent predictors of cardiovascular disease [3].
Our study shows that individuals with greater adiposity indices
were at greater risk of having diabetes and other cardiovascular
risk factors. The ROC analysis proved that measures of central
obesity (WHtR and WC) showed higher discriminative ability for
FPG, diabetes, atherogenic dyslipidemia and MetS than BMI or
body weight, but not for hypertension. Contrary to our
expectations, no significant differences were found between the
predictive abilities of WHtR and WC.
The general findings of the present study are in agreement with
those of previous studies which showed that the AUC for WHtR
was similar to WC at predicting diabetes and related risk factors
[21,22]. A systematic review published by Browning et al., which
analysed the predictive value of several adiposity indices for CVD
and metabolic conditions, showed that in 86% of studies in men
and 91% in women the AUC of WHtR was higher than or equal
to WC [10]. This could be explained because both measurements
reflect central adiposity and WHtR was calculated using WC.
Some authors have suggested correcting waist circumference for
the height of the individual, so the waist-to-height-ratio has been
proposed as a useful tool for assessing abdominal obesity [6,22,23].
In addition, as height has been inversely associated with
cardiovascular diseases (CVDs), it may be important to correct
waist circumference for height [24]. The importance of this point
is further highlighted if we take into account that height remains
quite unchanged during adulthood, so WHtR will change only
when there is a change in the waist measurement, whereas other
indices, such as waist-to-hip ratio are more sensitive to changes in
body size, and both hip and waist could increase or decrease
proportionately. Furthermore, the meta-analyses that have been
carried out support the evidence that measures of centralized
obesity, especially WHtR, are better at detecting cardiovascular
risk factors in both men and women than BMI or other
anthropometric measurements [7,8].
In our study, BMI appeared to be the anthropometric
measurement which better discriminates the prevalence of
hypertension. This result is consistent with a previous study of
3006 Chinese adults in which, the BMI OR for hypertension was
higher than measures of central obesity in men [25]. Furthermore,
although the great majority of studies assessing anthropometric
measurements and the prevalence of diabetes have shown a
positive association between BMI and diabetes, our study has not;
in just the same way that it was not found in a cross-sectional
population-based study conducted in 5073 Iranian women [26].
Hadaegh et al. also showed no significant risk across BMI and
incident diabetes in a prospective cohort of men [27].
In line with other studies, our results suggest that measures of
central obesity (WHtR and WC) are more associated with MetS
than other anthropometric measurements. The AUCs of WHtR
and WC were significantly higher than the AUCs of BMI and
body weight, and the predictive capability of these measures for
MetS is quite good (higher than 70%). Previous studies also found
that WHtR may be the most effective anthropometric index for
screening MetS in different populations [11,28].
Several studies have examined the association between anthro-
pometric measurements and hypertriglyceridemia or hypercholes-
terolemia [22,29]; even though we found that no studies assessed
the association of these measurements with atherogenic dyslipide-
mia prevalence. In our population, measures of central obesity also
showed higher discriminative ability for atherogenic dyslipidemia
than body weight.
The main limitation of the present study was the use of cross-
sectional data to assess the ability of anthropometric measure-
ments to predict CVD risk factors. Further longitudinal analyses
will provide stronger evidence of these associations. Another
limitation was that the analyses were conducted in an elderly
population at high risk for CVD, these individuals were included
in the PREDIMED study for having either type-2 diabetes or
other CVD risk factors, so they do not represent the usual
variability that we could find in the general population, and results
may not be extrapolated to the general population. It should be
kept in mind the potentiality for reverse causality bias. It is highly
plausible that individuals who have several cardiovascular risk
factors or are obese receive more advice from their physicians or
dieticians than general population, so they would be more likely to
improve their lifestyle and their dietary habits. However, the
sample of individuals studied was larger than that of most previous
studies and they were all subjects at high cardiovascular risk. This
strongly reinforces the interest of our results. Moreover, no
previous studies have been conducted in elderly Mediterranean
individuals at high cardiovascular risk, so our results extend
knowledge on the association between adiposity and disease in this
particular population where the earlier detection of cardiovascular
risk factors is essential if CVD is to be prevented.
In conclusion, measures of abdominal obesity (WHtR or WC)
showed higher discriminative ability for diabetes mellitus, high
fasting plasma glucose, atherogenic dyslipidemia and metabolic
syndrome than BMI or body weight in a large cohort of elderly
Mediterranean individuals at high cardiovascular risk.
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